Abstract |
A 72-year-old previously healthy man visited our hospital with complaints of hoarseness and dysphagia. Computed tomography showed wall thickening of the thoracic esophagus; invasion to the left main bronchus, aorta, and right supraclavicular lymph nodes (LNs); right recurrent nerve LNs; and cardiac LN swelling. Esophagogastroduodenoscopy revealed an elevated tumor in the middle thoracic esophagus, which was similar to a submucosal tumor and had a longitudinal ulcer at its center. Pathologicexamination showed a tumor with a high N/C ratio, and immunohistochemical staining showed the tumor was CD56 and NSE positive, with a Ki-67 index >80%. We diagnosed esophageal neuroendocrine carcinoma (NEC), cT4N3M0, Stage IVa. We started chemotherapy with irinotecan and cisplatin (IP therapy) according to a regimen for small-cell lung cancer. After 3 courses of chemotherapy, the primary lesion and the LN swelling had almost disappeared. Esophageal NEC is relatively rare disease, so there are no standard established treatments. We report a case of esophageal NEC for which IP therapy was effective with the relevant literature cited.
|
Authors | Fukutaro Shimamoto, Takayuki Kii, Masahiro Goto, Shin Kuwakado, Hitoshi Nishitani, Tetsuji Terazawa, Ken Asaishi, Takahiro Miyamoto, Yoshitaka Kurisu, Kazuhide Higuchi |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 42
Issue 8
Pg. 993-6
(Aug 2015)
ISSN: 0385-0684 [Print] Japan |
PMID | 26321716
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Irinotecan
- Cisplatin
- Camptothecin
|
Topics |
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Camptothecin
(administration & dosage, analogs & derivatives)
- Carcinoma, Neuroendocrine
(complications, drug therapy)
- Cisplatin
(administration & dosage)
- Deglutition Disorders
(etiology)
- Esophageal Neoplasms
(complications, drug therapy, pathology)
- Humans
- Irinotecan
- Lymphatic Metastasis
- Male
- Tomography, X-Ray Computed
|